United Therapeutics Overview
United Therapeutics Target Price
Analysts' 12-month price predictions for UTHR.
Get informed when a big investor buys or sells
+ FollowShare Price
$549.47
Average Target Price
$633.29
15.3% upside
15.3% upside7 analysts in the last 4 months
High: $738 | Low: $516
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-07 | Morgan StanleyTerence Flynn | $516 |  6.1% downside |  |
| 2026-05-07 | Wells Fargo | $735 | 33.8% upside | |
| 2026-05-07 | Wells Fargo | $738 | 34.3% upside | |
| 2026-04-10 | Morgan StanleyTerence Flynn | $519 | 5.5% downside | |
| 2026-04-10 | Raymond James | $700 | 27.4% upside | |
| 2026-03-12 | Cantor FitzgeraldOlivia Brayer | $625 | 13.7% upside | |
| 2026-02-26 | H.C. WainwrightAndrew Fein | $600 | 9.2% upside | |
| 2026-01-06 | UBS | $645 | 17.4% upside | |
| 2025-11-19 | JefferiesEun Yang | $575 | 4.6% upside | |
| 2025-10-30 | H.C. WainwrightAndrew Fein | $525 | 4.5% downside | |
| 2025-10-30 | RBC CapitalLisa Walter | $587 | 6.8% upside | |
| 2025-10-29 | Morgan StanleyTerrance Flynn | $447 | 18.6% downside | |
| 2025-10-10 | Morgan StanleyTerence Flynn | $435 | 20.8% downside | |
| 2025-09-29 | UBS | $580 | 5.6% upside | |
| 2025-09-26 | RBC Capital | $569 | 3.6% upside | |
| 2025-09-10 | Cantor FitzgeraldOlivia Brayer | $525 | 4.5% downside | |
| 2025-09-05 | H.C. WainwrightAndrew Fein | $500 | 9% downside | |
| 2025-09-02 | JefferiesRoger Song | $564 | 2.6% upside | |
| 2025-07-31 | H.C. WainwrightAndrew Fein | $400 | 27.2% downside | |
| 2025-04-25 | Wells FargoTiago Fauth | $314 | 42.9% downside | |
| 2024-10-31 | Argus ResearchJasper Hellweg | $400 | 27.2% downside | |
| 2024-10-31 | H.C. WainwrightAndrew Fein | $425 | 22.7% downside | |
| 2024-09-23 | JefferiesEun Yang | $432 | 21.4% downside | |
| 2024-08-28 | OppenheimerHartaj Singh | $575 | 4.6% upside | |
| 2024-07-08 | UBSAshwani Verma | $370 | 32.7% downside | |
| 2024-06-12 | Wells FargoTiago Fauth | $350 | 36.3% downside | |
| 2024-05-02 | OppenheimerHartaj Singh | $400 | 27.2% downside | |
| 2024-02-12 | Goldman SachsChris Shibutani | $215 | 60.9% downside | |
| 2023-01-11 | Argus Research | $300 | 45.4% downside | |
| 2022-12-06 | Morgan Stanley | $330 | 39.9% downside | |
| 2022-12-06 | UBS | $320 | 41.8% downside | |
| 2022-12-05 | Goldman Sachs | $230 | 58.1% downside | |
| 2022-05-24 | J.P. Morgan | $238 | 56.7% downside | |
| 2022-05-24 | Jefferies | $245 | 55.4% downside | |
| 2022-05-24 | Credit Suisse | $247 | 55% downside | |
| 2022-05-24 | H.C. Wainwright | $255 | 53.6% downside | |
| 2022-04-19 | J.P. Morgan | $223 | 59.4% downside | |
| 2021-05-05 | Credit SuisseTiago Fauth | $205 | 62.7% downside | |